Gould Robert J - Insider Non-Derivative Transactions at Fulcrum Therapeutics, Inc. (FULC) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Nov 19, 2025, Gould Robert J's relationship to Fulcrum Therapeutics, Inc. (FULC) is Director, and currently has 484,864 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other FULC insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Gould Robert J - Insider Non-Derivative Transactions of FULC Common Stock

Gould Robert J - Insider Non-Derivative Transactions at FULC

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Nov 20, 2025	Sell -- (Common Stock)	15000	11.03	484864
Jan 14, 2023	Sell -- (Common Stock)	6766	15	499864